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Dengue virus syndrome is an emerging global health challenge which is endemic in
tropical countries like Pakistan. In recent years dengue incidences have increased
considerably in different areas of Pakistan with more sever impacts on urban and peri-
urban populations. This review is an effort to highlight the changing epidemiology of
dengue fever, role of Government of Pakistan in disease management and control using
preventive and community based approaches in the region. Moreover, there is an
emphasis on application of Wolbachia as novel, inexpensive and environmentally benign
candidate for control and eradication of dengue transmitting vectors.1. Introduction
Infectious diseases continue to plague the global community
with high rates (26%) of morbidity and mortality. The main
causes for transmittance of such emerging and reemerging dis-
ease outbreaks are unprecedented shifts in (a) environmental or
climatic conditions either due to anthropogenic activities, (b)
overlapping of geographical ranges, (c) change in land-use
patterns or (d) emergence of drug and insecticidal resistances
among vector populations [1,2]. Vector-borne diseases such as
Congo hemorrhagic fever, Malaria, Dengue, Yellow fever,
Chikungunya etc. account for a signiﬁcant threat to human
population in terms of health and economic losses all over the
world. Such outbreaks lead to widespread epidemics which may
result in deaths of many hundreds and millions of people
annually [3,4]. These diseases have been reported to exert more
devastating effects on developing or under transition countries.
Because different variables e.g. water and sanitation facilities,
population density, literacy rate etc. are the major players forspread of epidemics in such countries as compared to
developed ones, where main contributors include ambient
temperature, moisture or humidity along with rainfall patterns
[1,2,5–7]. Most of these transmitted ailments are concentrated
and prevalent with higher impacts in regions of South-East
Asia, Southern Europe, Western Paciﬁc and Eastern Mediter-
ranean countries, Latin America, Australia and Sub-Saharan
Africa [1,2,6,7]. As for instance, approximately 1.1 million
deaths at global scale have been attributed to malaria alone [8].
Around 91% deaths involving 86% of children (<5 years of
age) were recorded in Africa because of malaria [9].
Recently dengue fever (DF) has been recognized as one of
emerging infectious diseases worldwide. It represents a consid-
erable havoc to people living in urban and peri-urban localities
of tropics and subtropics [10]. The viral epidemic has led to
hospitalization of 20 million people with around 24000 deaths
as documented by Sulehri et al [7], which now has raised up
to 50–100 million infected people with 2.5 billion at risk of
contracting dengue [11,12]. Pakistan has experienced a number
of dengue outbreaks with more server impacts in recent years.
These outbreaks are affecting larger proportion of urban
population and putting signiﬁcant stress on health care
facilities. Unfortunately the magnitude and severity index of
the disease remains unreported due to deﬁciency and difﬁcultyan open access article under the CC BY-NC-ND
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prevalence of dengue virus infection and its associated
serotypes in Pakistan with importance of potential biological
control agents in eradication of the transmitting vector/s.
2. Dengue fever, signs and symptoms
Dengue globally affects 40% of world's population and oc-
curs in repetitive cycles (3–5 years interval). The ailment pre-
sents high fever accompanied by frequent headaches, nausea,
skin rashes, enlargement of lymph nodes, pain behind eyes,
severe muscular, bone and joint pains, epitaxis along with leu-
kocytopenia i.e. reduction in white blood cells count. Thus
render individuals more prone to viral infection. DF is also
characterized as bone break fever or bone crush fever due to
severe pain in joints and bones [6,7,12,14–18].
3. Virology and serotypes
Being a member of a medically important viral family, Fla-
viviridae, the virus possesses single stranded positive sense
RNA (+ve ssRNA). Albert Sabin in 1944 classiﬁed dengue virus
into four antigenically related but immunologically distinct se-
rotypes namely DENV-1, DENV-2, DENV-3 and DENV-4 [19–
25]. All DENVs comprise of three structural [Capsid (C),
membrane (prM/M) and envelope (E)] and seven nonstructural
proteins (NS1, NS2a, NS2b, NS3, NS4a, NS4b and NS5).
Each of these serotypes has been reported to exhibit extensive
genetic variability due to distinct genotypes. Each of these
genotypes is associated with severe dengue epidemics
[17,22,23,26].
4. Principal transmission vector, breeding habitats
and virus acquisition
The infection is usually transmitted through bite of infected
Aedes aegypti (Ae. aegypti) (female mosquito). The mosquito is
adapted to feed exclusively on human blood and is a day time
feeder [6,11,15,17]. Ae. aegypti is well-known for being suscepti-
ble to all dengue viral serotypes and as an efﬁcient vector with
capability of transmitting dengue virus to many individuals in
shorter time span [20,26,27]. This species of mosquito has spread
extensively in tropical and subtropical regions of the world as a
result of increased national and international trade, shipping and
tourism [6,11,15,17,28]. Aedes albopictus (Ae. albopictus) has also
been reported to transmit dengue viruses however to much lesser
extent [29].
Ae. aegypti usually breeds in dark places, stagnant water kept
in containers for (indoor and outdoor) storage, water coolers,
drums, barrels, plant saucers, open buckets, in used tyres and
places where rainwater collects. The mosquito unlike rural set-
tings is speciﬁcally adapted to urban and peri-urban settings (i.e.
cleaner environment). In such localities mosquito population
density has been reported to be proportional to human popula-
tion density. Moreover, breeding habitats of mosquitoes have
strongly been associated with elevated temperatures, water
supplies, sewage and sanitation facilities [6,15].
Virus is acquired by mosquito during blood meals of viremic
(infected) patients. The acquisition is followed by incubation
period (8–10 d) where viral genome is replicated within the
mosquito, transferred to salivary glands via intestinal tract ofmosquito. Mosquito then transmits virus to healthy persons upon
subsequent biting [17,21,30,31] and also to offsprings via trans-
ovarian transmission during reproductive cycles [7,21]. Once
inside the human host virus starts replicating within the target
organs like white blood cells, lymphatic tissues etc. and gets
released into blood following circulation [32].
5. Dengue viral syndromes
Depending upon age and immunological status dengue virus
results in clinically different syndromes ranging from (a) classic
DF characterized as a milder a typical ﬂu-like form with high
grade fever, head and body aches. It affects infants, young
children and adults but is not fatal. Nonspeciﬁc febrile sickness
with rashes has been reported in infants and young children.
While mild febrile syndrome with high fever, head and joint-
muscular pains along with skin rashes has been observed in
older children and adults (b) dengue hemorrhagic fever (DHF)
characterizes acute and continuous fever (40–41 C) lasting for
2–7 d, accompanying hemorrhagic manifestations (ecchymosis
and petechiae) with reduction in platelets. It may lead to liver
enlargement and circulatory dysfunction in severe cases, and (c)
dengue shock syndrome, a complicated and prolonged illness, in
which DENV-1 viral infection is followed by DENV-2 and
DENV-3. Thus exhibits symptoms of both DF and DHF. Such
infections lead to hypervolemic shock (i.e. increased plasma
leakage due to vascular permeability) and are associated with
higher morbidity and mortality rates [6,7,14,31,33–37].
Furthermore, dengue infections have been reported to be life
threatening upon coexistence in asthmatic and diabetic patients
or in individuals with other chronic diseases [31]. According to
Raza et al [12] and Mukhtar et al [38] approximately 250000–
500000 people suffer from DHF and/or dengue shock
syndrome and about 20000–25000 are succumbed to death
every year.
6. Dengue in Pakistan
Pakistan being a developing urban and agricultural economy
is more likely to be at risk of vector-borne epidemics. Mosquito-
borne diseases such as dengue have now become a public health
concern. This is due to exertion of considerable burdens of
morbidity, mortality and economic distresses in many parts of
the region. Over populated cities, lack of access to proper
sanitation facilities, unavailability and shortage of clean drinking
water, population inﬂuxes at massive scale and lack of aware-
ness about possible health effects posed by vector transmitted
pathogens are some of the leading causes of spread of mosquito-
borne diseases [1,2,39]. Moreover, raised ambient temperature,
huge population, overcrowded cities with poor resource
settings and lack of health facilities (in terms of vaccination
access and coverage) also serve as important prerequisites for
reproduction of mosquitoes. This situation further exacerbates
transmission of pathogens dwelling within these host vectors
causing long-term illnesses [31,40].
Dengue viral infection killing 365 individuals with 21597
positive cases is becoming endemic in Pakistan. The viral
epidemic persists all the year round with greater intensity in
months of October–December (post-monsoon period). Addi-
tionally, recent ﬂoods have enhanced the prevalence of dengue
in entire country through provision of large number of breeding
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[13,15,17,24,41].
7. Prevalence of dengue viral serotypes in Pakistan
Outbreaks of DF recorded during 1994–2004 showed prev-
alence of DENV-1 and DENV-2 serotypes in different regions
of Pakistan. Whereas DENV-3 was the commonest serotype in
2005 and led to severe dengue hemorrhagic infections in pre-
viously DENV-1 and DENV-2 sensitized populations. In recent
years Pakistan is experiencing dengue outbreaks either major or
minor mainly by DENV-2 and DENV-3 [42]. For instance, the
predominance and co-circulation of DENV-2 and DENV-3 se-
rotypes have been reported during 2006, 2007 and 2009 in
Pakistan. Research studies revealed that DENV-2 (subtype IV),
DENV-3 (subtype III) and DENV-4 prevailed in 2008. Like-
wise, serotype DENV-2 was reported to follow DENV-1 during
dengue epidemics in 2010. However DENV-2 and DENV-3
serotypes caused most critical outbreaks in 2011 [12,18,21,41]
suggesting that magnitude of dengue outbreaks is entirely
dependent upon serotype, strain of virus, density of infected
vector, number of susceptible individuals [25].
8. Demographical facts about DF in Pakistan
History of dengue outbreaks in Pakistan dates back to early
nineties (1990) usually after the commencement of rainy sea-
son. The ﬁrst ever case of dengue was reported in Karachi in
1994, followed by second dengue outbreak in Baluchistan in
1995 [6,7,18,43]. But now the infection is appearing on regular
basis with greater impacts in densely populated urban areas
including upper and central Punjab, Sindh (Hyderabad,
Karachi) etc. during and soon after the rainy season [43]. In
2004, 25 cases of dengue were reported from Karachi and
Islamabad. Around 500 positive cases (including 13 deaths)
were recorded in Karachi by the year 2005, followed by
5400 cases (55 deaths) in Nawabshah, Karachi, Sukhar,
Islamabad and Rawalpindi and a larger proportion of
dengue cases in Azad Jammu and Kashmir in 2006
[6,44,45]. Hyderabad, Karachi, Mirpurkhas, Haripur, Lahore,
Islamabad and Rawalpindi were the more affected areas
due to dengue outbreak with 2700 positive cases and 24
deaths in 2007. Likewise 1800 cases were reported in
Lahore in 2008, followed by 320 cases reported in
Gujranwala, Lahore and Sheikhpura in 2010 [46,47]. The
worst strike of dengue (DF and DHF) was witnessed in
2011, with >20000 cases (including 300 deaths), with major
havoc in Lahore followed by Faisalabad, Rawalpindi and
Sargodha [21,43].
9. Strategies for management and control of dengue
viral outbreaks
Since the epidemiology of DF with reference to Pakistan has
changed during the recent era with increased frequency of
occurrence and more drastic effects. Therefore immediate ac-
tions need to be taken for controlling dengue transmitting vector
in order to prevent widespread of epidemics. Government of
Pakistan has taken some crucial and important steps in managing
the disease by launching various health line projects and
awareness campaigns etc.10. Role of Government of Pakistan in reducing viral
epidemics at administrative level
Government of Pakistan as well as government of Punjab has
taken many initiatives at administrative level for controlling the
spread of disease. For instance, Punjab Health Line Project for
Dengue has been launched by government of Punjab for sharing
information on disease recognition (signs and symptoms),
identiﬁcation of epidemically affected areas along with provi-
sion of help to suspected individuals. The government has also
established 24/7 operating mobile teams for providing free
treatment to affectees with particular emphasis in rural areas [6].
11. Environmental management and community
based approaches for reduction of mosquito
population
Government of Pakistan has also taken environmental man-
agement initiatives in an effort to control dengue transmitting
vector. Specialized community based programs have been star-
ted for proper solid waste collection and disposal in addition to
improved water storage practices. The local community has been
actively engaged along with concerned (municipal and public
health) authorities to ensure street cleaning, proper drainage
systems and elimination of pools of stagnant water. Proper
coverage of water storage containers is made mandatory for
preventing access of female mosquitoes for egg laying. The
water air coolers must be emptied or drained out when not in
use. Water containing objects like plant saucers should be
removed from house-gardens, old tyres must be recycled or
disposed off properly [6,7,15,17,48]. Moreover latest GIS based
systems and tools are now being used for identiﬁcation and
mapping of hotspots for dengue infection in order to develop
and implement national preparedness plans such as disease
early warning and response systems [6,12,18,21].
12. Educational initiatives
Numerous awareness campaigns have been launched in as-
sociation with electronic and print media. Additionally, dengue
related information has also been included in the syllabi of
various educational institutes especially at school level [17]. The
Health Services Academy has also launched (12 months)
diploma courses in medical entomology and disease vector
control in Pakistan at postgraduate level for training the
manpower to effectively and efﬁciently deal with vector-borne
diseases [49]. Such programs will be more effective in
producing more specialists to address the challenges posed by
vector-borne diseases like dengue.
13. Reducing contact with dengue mosquito through
personal actions
One of the most important measures for reduction in dengue
virus transmission is the interruption of host-mosquito contact.
Individuals should wear full length pants, trousers and full
sleeved clothes to cover the limbs. The conventional measures
such as mosquito repellents or lotions must be used for protec-
tion and to avoid mosquito biting during day time hours.
Moreover coils, electric vapor mats, trap lights, insecticide
treated nets and curtains etc. should be used to prevent direct
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kept closed. Moreover, use of indoor air conditioning systems
for cooling can also be helpful in avoiding direct contact of
humans with transmitting vector [17].
14. Chemical methods for controlling mosquito
population
Spray teams have been assembled by governmental author-
ities. These teams are responsible for time to time spraying,
fumigation or fogging in residential areas and streets of various
cities [6]. Suitable and long-lasting insecticides such as larvicides
or adulticides are periodically applied to breeding habitats for
reducing and controlling vector population [7,17].
15. Discovering effective antiviral vaccinations
Since no effective treatment or medication is available for
dengue virus and/or fever to date. Therefore discovery of
effective antiviral drugs and/or vaccines capable of targeting
multiple serotypes of dengue virus is exigently needed. The
vaccination needs to be effective, must provide life time im-
munity against viral pathogens as well as lessen the risks of
formation of cross reacting antibodies [18,50]. Live attenuated
and inactive dengue viruses, cloned and chimeric viruses,
subunit and DNA vaccines are some of the approaches that
are recently being used for developing effective vaccination
for treating dengue viral infections [31].
Phytochemicals (plants and plant-derived compounds) have
always served as important source in discovery of many antiviral
drugs. Therefore activity of various plant-derived phenolic
compounds has been evaluated by the researchers. For instance,
Zandi et al [51] assessed antiviral activity of bioﬂavonoids
against DENV-2 serotype at different infectious stages and vi-
rus replication. They concluded that quercetin was most effec-
tive viral inhibitor amongst all the tested compounds. Similarly,
Carica papaya leaf extracts exhibited potential activity against
dengue on administration to dengue infected patient [52].
Moreover, signiﬁcance of various phytochemicals against DF
has been shared in details by Sohail et al [53].
Most recent advancements related to dengue speciﬁc antiviral
agents have been reviewed and explained explicitly by Julander
et al [50]. Idrees and Ashfaq [54] have also reviewed the potential
of siRNA as next generation therapeutic agents against dengue
viral infection. Reports have revealed that vaccination
(comprised of proteins from all the 4 viral strains) against
dengue virus is under trial and testing processes (on
monkeys). It is likely to be proved effective in treating the
disease caused by all serotypes [18]. Moreover, the trials of
tetravalent vaccines exhibited 89% sero-conversion against
four serotypes after administration of third dose. While the
administration of this vaccine in two doses provided 80%–90%
protection in children. Similar results for sero-conversion rates
have been recorded in adult volunteers for other vaccines pre-
pared by Walter Reed Army Institute of Research [7].
Furthermore, numerous academic and academy associated
research centers are actively engaged in discovering and
developing anti-dengue viral drugs with hopeful results [17].
Researches and fully funded projects on various aspects of
dengue virus and transmitting vectors (mosquito) with
reference to serotypic and genotypic analysis also need to belaunched by government of Pakistan on large scale at national
level for understanding disease development and
complications. These researches will hopefully be leading to
breakthroughs in discovering and developing ideal dengue
vaccines [55,56].
16. Biological methods for controlling mosquito
population
Due to absence of effective vaccination and/or antiviral
agents, current dengue vector control methods heavily rely on
usage of chemically-based insecticides. Though seem to be
useful in reducing larval or adult populations of mosquitoes
during dengue epidemics, these insecticides are effective against
Ae. aegypti population only over a small geographical scale.
Conversely, non-targeted populations of other insects are also at
risk of being affected by insecticides. Moreover accumulation of
these insecticides in various environmental compartments leads
to health and pollution problems along with evolution of
insecticidal resistance among mosquito populations over passage
of time. Hence, failure of chemical insecticide-based programs
in preventing disease incidences and their escalating costs,
especially in developing countries, has spurred the exploration
of novel, cost effective and environment friendly control mea-
sures. These strategies should be capable of efﬁciently elimi-
nating reliance upon such chemical toxins [16,57,58].
Biological control usually refers to introduction and/or
release of biological agents persisting in nature into particular
environment for controlling pests either through predation, dis-
ease or parasitism. These techniques have been widely utilized
for protection of agriculturally important crops and livestock
against pest outbreaks, plants or animals causing damage to
environment. However, application of such biological control
agents in public health sector is relatively recent approach that is
still at infancy. This strategy for combating and controlling
mosquito-borne epidemics has attracted the attention of many
researchers. Presently there exists numerous biological control
methods and many are under development process for control-
ling dengue vector for instance copepods, pathogenic bacteria
and fungi etc. [58–60].
17. Fish and copepods as biological control agents
Introduction of mosquito predators such as ﬁsh, spiders,
geckos and copepods (small crustaceans) is somewhat beneﬁcial
in combating mosquito-borne diseases. They prey or feed on
mosquito larvae thus minimizing the social distress [58]. Such
copepods trails for eradication of dengue have been conducted
in Honduras, Vietnam [60–63], where ﬁeld trails proved to be
successful together with government and community
participation. However being expensive and requiring
continuous intercessions these strategies are unlikely to be
implemented in peri-urban and urban communities [16,58].
18. Bioinsecticides as biological control agents
Constant monitoring and community interventions for ap-
plications of natural predators along with adverse environmental
impacts (including humans and nature) posed by chemically-
based insecticide vector control approaches. Additionally the
loss of sensitivity of these vectors against insecticides has
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i.e. biopesticides [64,65]. Microbial insecticides comprised of
microorganisms and their byproducts seem to be more
effective and valuable alternatives for vector reduction in
terms of target speciﬁcity and lower toxicity to pesticide user
[66]. The entomopathogenic bacterium Bacillus thuringiensis
subsp. israelensis (BTi) was found to be a safer alternative for
controlling mosquitoes. Larvicidal activities of BTi described
explicitly by Boyce et al [67] and Ben-Dov [68] have proven to
be very effective in eradication of mosquito larvae [69].
However, short residual activity of BTi formulations limits its
applicability in controlling mosquito-borne diseases [70].
Use of fungi as biocontrol agents has also been proposed
because of their natural tendency to produce infective spores
(conidia). These spores can adhere and penetrate within insect's
cuticle where they ﬂourish on nutritional reserves of host along
with release of toxins that eventually kill the host [71]. Beauveria
bassiana has emerged as potential candidate for control of Ae.
aegypti causing signiﬁcant mortality at larval as well as adult
phases [58]. Metarhizium anisopliae has also been reported to
cause higher mortality in adult Ae. aegypti [72]. Luz et al [73]
and Garcia-Munguia et al [74] documented that fungal
infection not only kills Ae. aegypti larvae and adults but also
reduces fertility and slay the eggs. Such applications offer
effective control of vector population with slow evolution of
fungal resistance in contrast to insecticides. However the
application and implementation of fungal formulations requires
lots of research about the effects exerted by fungi on mosquito
vectors, as these evidences revealed success stories from
laboratories instead of ﬁeld settings [75].
19.Wolbachia as biological control agent
Microbes associated with numerous arthropod vectors e.g.
symbiotic bacteria as potential biocontrol agents have now
gained much of attraction due to their ability to interfere with
transmission of pathogens. Use of endosymbionts such as
Wolbachia pipientis (W. pipientis) for control of pathogen
transmission through mosquito vectors has been reported by
Bordenstein and Rosengaus [59] and Thomas et al [76]. W.
pipientis has recently emerged as biological weapon for
control of mosquito-borne diseases because of its natural capa-
bility of interfering with viruses persisting within mosquitoes,
environmental benignity and cost effectiveness in contrast to
chemical control methods [16,76,77].
W. pipientis is a Gram negative bacterium having intracel-
lular lifestyle and infects somatic and germ line tissues of hosts
[78]. The bacterium is known to infect up to 70–76% insect
species existing on earth [16]. The bacterium usually resides in
insects, ﬁlarial nematodes, arachnids, crustaceans and different
arthropod species [79–82]. Wolbachia is known to have an
essential role in embryogenesis, induction of alterations in
reproductive cycles of hosts, as antibiotic treatment of infected
individuals and in animals for inhibition of microﬁlariae [81,83].
Utilization of W. pipientis for controlling mosquito-borne
diseases has been pursued as a recent strategy with more
promising results to alter Ae. aegypti populations and reduce
their capability to transmit dengue virus pathogens in humans
[84,85]. A number of different Wolbachia strains including wMel
and wMelPop from Drosophila and aAlbB from Ae. albopictus
have been reported to be introduced into Ae. aegypti [86,87].
Wolbachia invades and sustains itself inside mosquitoes whereit induces series of reproductive abnormalities within the host
for increasing reproduction of female mosquitoes. Thereby
enhancing their own reproduction and transmission within host
populations [16,79,88,89]. These reproductive abnormalities
include feminization (transformation of genotypic males into
phenotypic females), modiﬁcations within male sperm and
parthenogenic reproduction of females along with other
behavioral effects plus altering the biting position etc. [16,89].
The bacterium has also been reported to affect nutritional
status, development of their hosts, reduction of host's lifespan
due to over-replication and occupation of brain tissues of the
infected hosts and interference with pathogen replication [16,90–
92].
Before migration into salivary glands of mosquito and
transmission into humans, dengue virus requires sufﬁcient in-
cubation period. Hence lifespan of mosquitoes is very critical in
disease transmission. Consequently wMelPop strain has been
proposed to alter and shorten the lifespan of Ae. aegypti and
favors elimination of older mosquitoes to lessen the risks of
dengue transmission [90,93]. Similarly, wMel strain has also been
reported to reduce (adult) mosquito's lifespan around 10% [94].
Wolbachia transfections can also induce cytoplasmic in-
compatibilities a type of embryonic lethality that occurs during
mating of Wolbachia infected males with uninfected females.
Thereby causes reduction in egg hatching and producing unvi-
able offsprings [58,95]. Cook et al [96] and Helinski et al [97]
reported transfection of Ae. aegypti with two Wolbachia
strains namely wMel (benign) and wMelPop (virulent) and
observed induction of cytoplasmic incompatibilities within
their hosts. Such transfections offer a reproductive advantage
to Wolbachia infected females over uninfected populations due
to reduction in fecundity of uninfected females and impacting
dengue virus transmission [98]. The cytoplasmic incapability is
basically meant for Wolbachia for enhancing number of
infected individuals within host population in order to boost
their own maternal transmission [85].
To date many stable Wolbachia transfected cell lines have
been established and maintained for controlling disease trans-
mitting vector (Ae. Aegypti). McMeniman et al. [92] transferred
wMelPop into Ae. aegypti after 4 years of maintenance of
Wolbachia within Ae. albopictus and generated stable
wMelPop-CLA (cell-line-adapted) lines with 100% maternal
transmission rates. These transfected mosquitoes have exhibited
50% reduction in adult lifespan in contrast to uninfected coun-
terparts [92,99,100]. Similarly wAlbB strain of Wolbachia (from
Ae. albopictus) has also been transfected successfully into Ae.
aegypti [101].
Additionally, Wolbachia transinfections have also been re-
ported to reduce the susceptibility of Ae. aegypti to dengue virus
[102]. As depicted by Pan et al [103] that wAlbB transfected Ae.
aegypti exhibited inhibition of dengue virus due to activation
of ROS of Toll pathway. Such Wolbachia mediated pathogen
interferences have caused signiﬁcant reduction in competency
of vector for dengue virus. These transfections also offer some
sort of protection against DENV within mosquito cell lines
despite lack of whole organism or tissue speciﬁc immunity
within these cells [94,101,104,105].
Moreover, considerably higher bacterium transmission fre-
quencies to next progeny of Wolbachia transfected mosquitoes
(females) have been documented by McMeniman et al [92],
where the bacterium invades uninfected populations by
inducing reproductive abnormalities. Thus favors propagation
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efﬁciency of wMelPop-CLA strains has been reported in off-
springs of transinfected Ae. aegypti [92]. wMelPop-CLA trans-
fection in Ae. aegypti are known to induce higher metabolic rates
in mosquitoes [107], feeding impairments in older mosquitoes
[108], reduced hatching and egg survival during phases of
dormancy [109]. Such transfections suggest Wolbachia as best
control strategies against dengue vector by suppressing egg
hatching in wet seasons [16]. Furthermore, modiﬁcations in
larval nutritional levels, duration of larval development as well
as wing size of male Ae. aegypti has also been observed by
Barrett et al [110] and Yeap et al [111]. wMelPop-CLA infected
mosquitoes also showed signiﬁcant reduction in replication of
DENV-2 along with 56% reduction in fertility of infected fe-
males as compared to uninfected ones [94,104]. Additionally,
reduction in blood meal ingestion by wMelPop-CLA trans-
fected mosquitoes has been observed by Turley et al [108] and
Moreira et al [112]. All the three types of Wolbachia i.e. wMel,
wMelPop and wAlbB have been reported to inhibit dengue
virus replication at signiﬁcant levels along with dissemination
within Ae. aegytpi population, thereby causing either partial or
complete blockage of virus transfer in humans [94,101,104].
Analysis of pooled saliva extracts revealed complete blockage
of viral transmission by wAlbB and wMelPop-CLA infected
mosquitoes [94].
Wolbachia transfections within host tissues have been re-
ported to interfere with DENV replication where the bacterium
competes for cellular resources and sequesters fatty acids of host
cells that are required for DENV replication [104,113,114]. The
immunoﬂuorescence studies of Wolbachia transfected Ae.
aegypti revealed no co-localization of bacterium with dengue
virus and suggested metabolic competition between the two
[104]. This phenomenon has been illustrated in detail by Bourtzis
et al (2014). This metabolic competition is further supported by
the fact that signiﬁcant differences were observed in density as
well as tissue distribution between wMel and wMelPop strains
(though closely related to each other) in infected Ae. aegypti.
This wMelPop strain is known for boosting phenotypic
interferences in mosquitoes against dengue virus due to higher
concentration [94,104]. Studies have also revealed a strong
negative correlation between genome copy of dengue virus
and Wolbachia, where dengue infection has been inhibited
completely at Wolbachia density of up to 961.8 wsp/actin
[115]. This has suggested dependency of Wolbachia mediated
viral interferences on bacterial density within the transfected
hosts [16].
Many researchers have reported that Wolbachia strains
utilize host microRNAs (miRNAs) for altering and manipu-
lating gene expression of host and displaying antiviral response
by establishing infections in Ae. aegypti [116–120]. The
upregulation of host aae-miR-2940 in cell lines of Wolbachia
transfected mosquitoes has been reported by Hussain et al [116]
where it targets metalloprotease genes and facilitates
colonization of bacterium within the host. Similarly
Wolbachia exploits this MiRNA of Ae. aegypti for targeting
methyltransferase gene DnmmtA2 and alters it expression
which eventually interferes with dengue virus replication.
This interference inhibits virus establishment within the host
thus providing a pathway for controlling disease
transmission. Moreover, induction of aae-miR12 by Wolba-
chia down regulates DNA replication (MCM6) and mono-
carboxylate transporter (MCT1) genes. Therefore, plays animportant role in maintaining Wolbachia infection within cell
lines of host [117].
Field trials for release of Wolbachia infected mosquitoes
have been performed in different countries. For instance, wMel
infected Ae. aegypti were introduced in two towns in North
Queensland, Australia during wet season where wMel strains
successfully invaded and transformed the local populations of
Ae. aegypti within few months of being released [118–122]. While
persistence of virus blocking property of Wolbachia in ﬁeld
released infected mosquitoes was conﬁrmed by Frentiu et al
[123]. These trials suggested that Wolbachia strains can
efﬁciently be deployed as biocontrol agents against dengue
vectors. No further evidences of transfer of bacteria into
humans via mosquito bites, or the lateral transfer to nontarget
species as well as to mosquito predators has been observed
[16]. But the likelihood for horizontal transfer of Wolbachia
DNA within mosquito genomes has been reported by
McNaughton et al [124] and Popovici et al [125].
20.Wolbachia based biocontrol research being
carried out in Pakistan
The Wolbachia strains that have already been explored and
successfully exploited in other parts of the world can also be
evaluated for stopping dengue virus transmission through erad-
ication of vector populations in Pakistan. However imple-
mentation and application of such control strategies is largely
dependent upon geographical and climatic conditions of partic-
ular settings, scientiﬁc evidences as well as region speciﬁc
appropriateness [126]. Therefore, scientiﬁc community needs to
explore the potentials of native or indigenous endosymobiotic
strains and their transfer within Ae. aegypti. Many research
projects in collaboration with international institutes are
currently being conducted in Pakistan for reduction in
transmission of dengue virus. For example, a project aimed at
making Ae. aegypti incapable of carrying and transmitting
dengue virus in humans through genetic modiﬁcations using
Wolbachia has been launched in collaboration with Michigan
State University, USA at Government College University,
Lahore [127]. Moreover, interagency partnerships and
collaborations of research organizations for Wolbachia based
control technologies in Pakistan can be helpful in providing
new means and tools for precise assessment of Wolbachia
transfections in mosquitoes, their impact on vector population
as well as role in blocking virus transmission etc. These
collaborations among research organizations at international
level may facilitate and strengthen the research networks by
encouraging capacity building. They can also play crucial role
in ﬁlling the funding gaps that hinder focused research efforts
[128,129]. Resource mobilization, political participation and
support are also needed to promote the efforts being made to
prevent and control dengue using biological control agents in
the region. Government of Pakistan and higher education
commission needs to setup and release dengue virus research
funds for reproducing researches going on in other parts of the
world like Australia, USA and British biotechnology company
Oxitec etc. [129,130]. Such initiatives will encourage the
researchers to explore and evaluate the capability of
indigenous Wolbachia species to eliminate dengue epidemics
through high-tech facilities and equipment. Various institutes
of Pakistan intend to collaborate with international institutions to
ﬁgure out the potentials and implementation of W. pipientis for
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region.
Though W. pipientis seems to be very efﬁcient in reduction
and eradication of dengue vector, still the interactions and mo-
lecular mechanisms which affect the performance of mosquitoes
are largely unknown. Moreover, effects exerted by Wolbachia
on dengue virus transmission and epidemiology in endemic
areas are yet ambiguous and require large scale clinical trials
before being released into ﬁeld [131]. These untold stories have
opened new portals for research activities to understand
biological and evolutionary relations between Wolbachia and
their symbionts. The knowledge obtained can potentially be
applied for control of mosquito-borne diseases.
21. Conclusions
Prevalence of dengue epidemics throughout Pakistan is a
leading cause of morbidity and mortality of thousands of in-
dividuals every year. This situation has spurred the development
of effective control measures for controlling and eradicating the
transmission vectors. Though many efforts at governmental and
community levels have been made to effectively deal with Ae.
aegypti. Unfortunately the failure of chemical based strategies,
development of resistance against insecticides with subsequent
threats to humans and environment, hurdles in implementation
of other biological control measures due to effectiveness over
small geographical scales has forced the scientiﬁc community to
discover economically feasible and environment friendly alter-
natives. Wolbachia mediated vector control strategies as
described above offer promising results for control of dengue
virus. Though still at infancy this strategy seems to be very
effective without posing any threat to human health as well as
the environment. So there is a dire need to explore the potentials
of native and/or indigenous endosymobiotic Wolbachia strains
and their transfer within Ae. aegypti for ensuring our region to be
free of dengue virus. All this seems to be possible only with
support of government and private funding agencies.
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